VEGFA and wet macular degeneration: Our data showed that only intervention through targeting the Vegfa gene at the neoangiogenic phase of CNV could promote the cure of wet AMD, while disrupting the Vegfr2 gene slightly but not significantly reducing CNV lesion area, indicating that targeted disruption of Vegfr2 was not as efficient as Vegfa.